Form 8-K - Current report:
SEC Accession No. 0001437749-25-004824
Filing Date
2025-02-24
Accepted
2025-02-24 08:00:15
Documents
14
Period of Report
2025-02-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 FORM 8-K vxrt20250222_8k.htm   iXBRL 8-K 26501
  Complete submission text file 0001437749-25-004824.txt   158986

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA vxrt-20250221.xsd EX-101.SCH 3409
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vxrt-20250221_def.xml EX-101.DEF 11424
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vxrt-20250221_lab.xml EX-101.LAB 15310
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vxrt-20250221_pre.xml EX-101.PRE 11584
16 EXTRACTED XBRL INSTANCE DOCUMENT vxrt20250222_8k_htm.xml XML 2833
Mailing Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 170 HARBOR WAY, SUITE 300 SOUTH SAN FRANCISCO CA 94080 (650) 550-3500
Vaxart, Inc. (Filer) CIK: 0000072444 (see all company filings)

EIN.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 25654266
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)